A detailed history of Wynn Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wynn Capital, LLC holds 21,064 shares of MRK stock, worth $2.05 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
21,064
Previous 20,831 1.12%
Holding current value
$2.05 Million
Previous $2.58 Billion 7.25%
% of portfolio
1.57%
Previous 1.91%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$111.15 - $128.97 $25,897 - $30,050
233 Added 1.12%
21,064 $2.39 Billion
Q2 2024

Jul 18, 2024

BUY
$123.8 - $132.96 $26,493 - $28,453
214 Added 1.04%
20,831 $2.58 Billion
Q1 2024

Apr 10, 2024

SELL
$113.24 - $131.95 $87,761 - $102,261
-775 Reduced 3.62%
20,617 $2.72 Billion
Q4 2023

Feb 01, 2024

BUY
$100.18 - $109.02 $2.14 Million - $2.33 Million
21,392 New
21,392 $2.33 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Wynn Capital, LLC Portfolio

Follow Wynn Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wynn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wynn Capital, LLC with notifications on news.